| Literature DB >> 28912090 |
Ryan M Hickey1, Laura M Kulik2, Halla Nimeiri3, Aparna Kalyan3, Sheetal Kircher3, Kush Desai4, Ahsun Riaz4, Robert J Lewandowski4, Riad Salem5.
Abstract
Immunotherapy, specifically the use of immune checkpoint inhibitors, offers a new approach to fighting cancer. Although the results of treatment with immune checkpoint inhibition alone have been remarkable for certain cancers, these results are not universal. Preclinical and early clinical studies indicate the potential for synergistic effects when immune checkpoint inhibition is combined with immunogenic local therapies such as ablation and embolization. This review offers an overview of immunology as it relates to immune checkpoint inhibition and the possibilities for synergy when combined with interventional radiology treatments.Entities:
Mesh:
Year: 2017 PMID: 28912090 DOI: 10.1016/j.jvir.2017.07.018
Source DB: PubMed Journal: J Vasc Interv Radiol ISSN: 1051-0443 Impact factor: 3.464